CTVolunteerBanner

Current Clinical Trials

 

Currently Enrolling

 

GI NATURAL HISTORY
A Two-Year Prospective Longitudinal Study using Quantitative and Qualitative Assessments to Define the Natural History of Gastrointestinal Symptoms in Patients with Parkinson’s Disease or at Risk for Developing the Motor Symptoms of Parkinson’s Disease.  Click here for flyer

 

PERFORM STUDY
Outpatient Physical Therapy Intervention in Subjects with Parkinson' Disease Currently Using APOKYN®.  Click here for flyer.

  

RESTORE
A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of droxidopa therapy. Click here for flyer

  

BIOTIE
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients with Parkinson’s Disease Experiencing End-of-Dose “Wearing-Off” (TOZ-PS).
  Click here for flyer

 

PPMI
The Parkinson’s Progression Markers Initiative.   Click here for flyer

 

NPF-QII
National Parkinson Foundation Quality Improvement Initiative

 

CALA
Multicenter Study of Safety and Effectiveness of Cala ONE Device for Essential Tremor.   Click here for flyer

 

 

Let us know if  you or someone you know is interested in participating in one of the Actively Recruiting Clinical Trials:

 




Not Actively Recruiting
DISCOVERY-PD
Proteomics, Metabolomics, Lipidomics and Genetic Analysis for Biomarker DISCOVERY in Parkinson’s Disease 

EASE LID 3
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia (EASE LID 3)

 

ACORDA

A Phase 3, Randomized Study Investigating the Safety of CVT-301 (Levodopa Inhalation Powder) in Parkinson’s Disease Patients With Motor Response Fluctuations (OFF Phenomena) Compared to an Observational Cohort Control

675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)